Earnings Call · Q2 FY2022·2022-02-01

Q2 22EPS +4.44%·Rev n/aQ1 22EPS +6.98%·Rev n/aQ4 21EPS +9.30%·Rev n/aQ3 21EPS +15.38%·Rev n/a⚠ consensus missing

BIO-TECHNE Corp TECH

David Clair — Senior Director, Investor Relations and Corporate Development

Chuck Kummeth — Chief Executive Officer

Jim Hippel — Chief Financial Officer

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TECH calls or request research access.

More TECH calls Browse calls Request research access